Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain. | Nat Commun | 2023 | 37626045 | PubTator, text mining | PubMed |
| Both chloride-binding sites are required for KCC2-mediated transport. | J Biol Chem | 2023 | 37625593 | PubTator, text mining | PubMed |
| Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities. | Cancers (Basel) | 2023 | 37568749 | PubTator, text mining | PubMed |
| Editorial: Images from red cells, Volume II. | Front Physiol | 2023 | 37565144 | PubTator, text mining | PubMed |
| Cryo-EM structures of human zinc transporter ZnT7 reveal the mechanism of Zn2+ uptake into the Golgi apparatus. | Nat Commun | 2023 | 37553324 | PubTator, text mining | PubMed |
| Molecular characterization of colorectal adenoma and colorectal cancer via integrated genomic transcriptomic analysis. | Front Oncol | 2023 | 37546388 | PubTator, text mining | PubMed |
| Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. | Int J Mol Sci | 2023 | 37511126 | PubTator, text mining | PubMed |
| Landscape of Genetic Mutations in Appendiceal Cancers. | Cancers (Basel) | 2023 | 37509254 | PubTator, text mining | PubMed |
| Changes in expression levels of erythrocyte and immune-related genes are associated with high altitude polycythemia. | BMC Med Genomics | 2023 | 37507679 | PubTator, text mining | PubMed |
Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity. | Front Pharmacol | 2023 | 37492092 | PubTator, text mining | PubMed |
| Cognitive perspectives on maintaining physicians' medical expertise: II. Acquiring, maintaining, and updating cognitive skills. | Cogn Res Princ Implic | 2023 | 37488460 | PubTator, text mining | PubMed |
| Geodesic theory of long association fibers arrangement in the human fetal cortex. | Cereb Cortex | 2023 | 37482884 | PubTator, text mining | PubMed |
| Affinity-selected heparan sulfate collagen device promotes periodontal regeneration in an intrabony defect model in Macaca fascicularis. | Sci Rep | 2023 | 37479738 | PubTator, text mining | PubMed |
| A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape. | Front Oncol | 2023 | 37476379 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma. | Front Genet | 2023 | 37470034 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of a four-gene signature based on EMT in the prognosis, immunity, and treatment of lung squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37462692 | PubTator, text mining | PubMed |
| TGF-β based risk model to predict the prognosis and immune features in glioblastoma. | Front Neurol | 2023 | 37456651 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning. | Front Pharmacol | 2023 | 37426809 | PubTator, text mining | PubMed |
| Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia. | Leukemia | 2023 | 37422594 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=8